Portfoliobreadcrumb nav

Nkure Therapeutics - biotechnology firm

Nkure Therapeutics
Founders Image

Nkure Therapeutics is a pioneering biotech platform for development of Natural Killer (NK) cell therapies for cancer treatment. Their mission is to make cutting-edge and affordable immunotherapies accessible, with a focus on improving patient outcomes and extending Indian innovation globally.

Sector

Lifesciences

#
NK Cell Therapy
#
Biologics

Milestones

  • Partnered in 2023

Founders

Dr Mahendra Rao
Dr Mahendra Rao

Investment Team

Dr. Ramesh Byrapaneni
Dr. Ramesh Byrapaneni
In the News
SEE ALL
Lifesciences

BioPharmaAPAC

May 8, 2025

India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics

Strategic collaboration to co-develop CTX112™ aims to address India’s growing burden of B-cell lymphomas with an off-the-shelf, CRISPR-engineered cell therapy offering scalable production and reduced treatment delays.

India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics
Lifesciences

Economic Times

April 27, 2023

Nkure raises pre-Series A round

The company is pioneering affordable NK cell therapy for the treatment of Cancer. Nkure is scaling rapidly from its first year of inception having successfully developed an NK cell platform at laboratory scale coupled with agreements with CDMOs in India and the US. It has also secured exclusive licenses to a specialized CAR and related technologies to enable allogenic cell therapy, the first of its kind in India.

Nkure raises pre-Series A round